United Kingdom · Biotechnology startup
United Kingdom · Ascend Gene And Cell Therapies Ltd.
Ascend is an England-based company that provides services such as formulation development, clinical manufacturing and regulatory support for biotech companies.
Funding reportedLast round: Series A
What company datasets say Ascend Gene And Cell Therapies Ltd. raised
Funding, as reported
Reported in all132.5Min the source's currency
Rounds2
Last roundSeries A
Last round size66.6M
Last round dateMay 2023
Investors listed8
Funding filed with regulators
Ascend Gene And Cell Therapies Ltd. filed 5 raises, $133M in all. Filings say how much was sold and to how many investors; they never name the investors.
- May 2024$42MUK share allotment
- Apr 2023$3.3MUK share allotment
- Mar 2023$6.5MUK share allotment
- Feb 2023$66MUK share allotment
- Dec 2021$15MUK share allotment
The company, in detail
What they build
Built with from their website
Microsoft 365Outlook
- Sector
- Biotechnology
- Region
- England
- Full record
- Every detail in the company directory
Biotechnology in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Ascend Gene And Cell Therapies Ltd. in front of investors. Or tell us what we have wrong.